Cough Syrup Testing

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Distributors of a contaminated Indian cough syrup that killed 65 children in Uzbekistan paid local officials a bribe of $33,000 to skip mandatory testing, Uzbek state prosecutors

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

The direction has come after quality concerns were raised globally for cough syrups exported by Indian firms.

Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.

The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.

Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.

From the ruling Congress, to the opposition AAP, politicians in Punjab are lining up to take dope tests in an attempt to prove they are serious about fighting the drug menace in the state. This comes after Chief Minister Amarinder Singh earlier this week ordered bureaucrats in the state to get themselves tested.

Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or

Distributors of a contaminated Indian cough syrup that killed 65 children in Uzbekistan paid local officials a bribe of $33,000 to skip mandatory testing, Uzbek state prosecutors

Cough syrup from a Haryana-based firm that allegedly caused deaths of children in Gambia, has passed all tests, sources in Union Health Ministry told NDTV today.

The direction has come after quality concerns were raised globally for cough syrups exported by Indian firms.

Amid quality issues being raised globally for the cough syrups exported by Indian firms, the Centre is actively considering a proposal of testing drugs at government laboratories before they are dispatched to other countries.

The production licence of Noida-based pharmaceutical firm Marion Biotech, allegedly linked with the deaths of children in Uzbekistan, has been suspended while the test results of its controversial cough syrup are awaited, an UP drug official said.

Drugs Control Department has directed drug manufacturers that certificate of analysis of glycerin and propylene glycol procured in the last one year should be submitted within seven days

India is testing samples of the cough syrups produced by Maiden Pharmaceuticals after the World Health Organisation said its products were linked to the deaths of dozens of children in the Gambia.

From the ruling Congress, to the opposition AAP, politicians in Punjab are lining up to take dope tests in an attempt to prove they are serious about fighting the drug menace in the state. This comes after Chief Minister Amarinder Singh earlier this week ordered bureaucrats in the state to get themselves tested.